GlaxoSmithKline

GlaxoSmithKline (GSK) is a top pharmaceutical company based in London, United Kingdom and Philadelphia, USA

GlaxoSmithKline (GSK) is a top pharmaceutical company based in London, United Kingdom and Philadelphia, USA.The company source its origins back to 1715, however the most recent incarnation is the result of numerous M&A deals over the decades resulting in the 2000 merger between Glaxo Wellcome and SmithKline Beecham.

The company are a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Products are used by millions of people around the world, helping them to do more, feel better and live longer.

GSK have three primary areas of business in pharmaceuticals, vaccines and consumer healthcare.

Report: Partnering Deals and Alliances with GlaxoSmithKline

GlaxoSmithKline (GSK) is a top pharmaceutical company based in London, United Kingdom and Philadelphia, USA.

The company source its origins back to 1715, however the most recent incarnation is the result of numerous M&A deals over the decades resulting in the 2000 merger between Glaxo Wellcome and SmithKline Beecham.

The company are a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Products are used by millions of people around the world, helping them to do more, feel better and live longer.

GSK have three primary areas of business in pharmaceuticals, vaccines and consumer healthcare.

GSK’s commercial success depends on creating innovative new products and making these accessible to as many people who need them as possible. By achieving this, GSK will be able to grow business and provide benefits to patients, consumers, society, our employees and our shareholders.

The company has three core businesses:

Pharmaceuticals - researches, develops and makes available medicines that treat a variety of serious and chronic diseases

Vaccines - one of the largest in the world, with nearly 900 million doses distributed to 170 countries in 2012

Consumer healthcare - market a range of consumer health products based on scientific innovation

GlaxoSmithKline has an active licensing partnering group that combining expertise is key to innovation and success.

GSK know that many of the best ideas can come from outside of GSK, and collaborating with other companies, organisations and academics is a fundamental part of its business strategy. GSK are therefore committed to working with partners to deliver innovative new medicines, vaccines and consumer healthcare products more

GSK announced over 380 partnering / licensing deals since 2005, with 50 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in oncology, infectives, central nervous system and gastrointestinal diseases more

Novartis has also announced 16 M&A deals since 2005, with the lead deals being the acquisition of Human Genome Sciences and Stiefel more

Report: Partnering Deals and Alliances with GlaxoSmithKline

Examples of recent partnering and licensing deals announced by GlaxoSmithKline can be viewed in Current Partnering's GlaxoSmithKline partnering activity review article.

Examples of recent M&A deals announced by GlaxoSmithKline can be viewed in Current Partnering's GlaxoSmithKline M&A activity review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with GlaxoSmithKline

Available reports from Current Partnering

Report: Partnering Deals and Alliances with GlaxoSmithKline  

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for GlaxoSmithKline

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on GlaxoSmithKline company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email